KERRI DAVIS: Open Payments
NPI 1942588827 · ELDERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 67 payments from 18 companies in 2025. Trend: 2023 $1,838 · 2024 $1,578 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $225 |
| Amgen Inc. | 12 | $184 |
| Novo Nordisk Inc | 8 | $153 |
| PFIZER INC. | 7 | $133 |
| Bausch Health US, LLC | 4 | $86 |
| Corium, LLC | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Lilly USA, LLC | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: QULIPTA, OTEZLA, APLENZIN, Azstarys, VRAYLAR, NURTEC ODT, PREVNAR 20, Rybelsus.
Industry payments across MD — which companies pay providers there.
